Google’s life sciences unit and French drugmaker Sanofi are teaming up to develop new digital technology and tools to help people with diabetes better manage their condition.
There is still huge unmet medical need in diabetes, given that less than a third of patients with type I and nearly half of all patients with type II forms of the condition are failing to meet their blood sugar targets, placing them at much higher risk of serious complications.
“With new technologies emerging to provide a more continuous and real-time view of a patient’s health, we can see the promise for more proactive and effective ways to control diabetes,” said Andy Conrad, chief executive of the life sciences team at Google. “Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life.”
“This initiative combines Sanofi’s strength and knowledge in diabetes with Google’s leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care,” added Sanofi’s chief Olivier Brandicourt.
Terms of the collaboration were not released.
